InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,833.60
(
0.98%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.54
(
-0.91%
)
Bitcoin
56,406.14
(
-1.01%
)
Post# of 13959
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Tome1310

Send PM Follow Ignore
Followers 0
Posts 86
Boards Moderated 0
Alias Born 02/04/2019

Tome1310

Re: Vlaotrd post# 2888

Thursday, 02/14/2019 8:14:32 PM

Thursday, February 14, 2019 8:14:32 PM

Post# of 13959
What ever happened to this merger?
And Bertilimumab has been in phase II since 2013. The stock has fallen since conception. Only Teper has shown any interest in the company?! No one was interested in partnership by potential alone. Their drugs they have in circulation clearly don't make any money. They went to Extera for help. This filing had zero optimism and zero updates on anything positive unlike recent filings. If anything good we're in the mix they'd let you know. I question the actual progress of their trials. I think they know about their actual demise and are sucking everyone on here dry. Just my opinion.

https://www.prnewswire.com/news-releases/immune-pharmaceuticals-completes-merger-with-epicept-corporation-221116351.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up